Skip to content

Clinical Evaluation of MyDay™ and 1-DAY ACUVUE® TruEye®

Clinical Evaluation of MyDay™ Daily Disposable Silicone Hydrogel Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02388763
Enrollment
66
Registered
2015-03-17
Start date
2015-04-30
Completion date
2015-09-30
Last updated
2016-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive Error

Keywords

Contact lenses

Brief summary

The purpose of this study is to evaluate the functional vision of 2 daily disposable silicone hydrogel contact lenses using Time Controlled Visual Acuity (TCVA) measurements at high luminance and high contrast after 10+/-3 days of wear post 3 hour exposure to a reduced humidity environment.

Detailed description

After randomization, participants attended a baseline visit to include a 3 hour exposure to reduced humidity environment. The participant's habitual lenses were worn for the baseline visit.

Interventions

Contact lenses worn during Period 1 or 2, as randomized

Contact lenses worn during Period 1 or 2, as randomized

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Must sign informed consent form. * Adapted, current soft silicone hydrogel daily disposable contact lens wearer during the last 2 months. * Willing to wear lenses every day or at least 5 days per week 6 hours per day. * Willing to discontinue artificial tears and rewetting drops usage on the days of study visits. * Other protocol-specified inclusion criteria may apply.

Exclusion criteria

* Monocular (only 1 eye with functional vision) or fit with only 1 lens. * Pregnant or lactating. * Current MyDay™ or 1DAY ACUVUE® TruEye® lens wearer. * Any abnormal ocular condition as specified in the protocol. * Other protocol-specified

Design outcomes

Primary

MeasureTime frameDescription
High Contrast Time-Controlled Visual Acuity (TCVA) (VA Unit) Post-Exposure to Reduced Humidity at Day 10Day 10, each productHigh contrast TCVA was assessed after 3 hours exposure to reduced humidity environment. TCVA test was performed at 4 meters under high illumination (90%) using a Landolt ring test. For each acuity level, a series of single rings with gaps in one of four directions was presented and the percentage of correctly identified rings constituted the score. TCVA was measured in VA units and a higher TCVA value indicates an improvement in visual acuity. Both eyes contributed to the analysis.

Secondary

MeasureTime frameDescription
High Contrast TCVA (VA Unit) Pre-Exposure to Reduced Humidity at Day 10Day 10, each productHigh contrast TCVA was assessed after 3 hours exposure to normal environment and prior to exposure to reduced humidity environment. Both eyes contributed to the analysis.

Participant flow

Recruitment details

Participants were enrolled from 1 investigative site located in the United Kingdom.

Pre-assignment details

Of the 66 enrolled participants, 2 participants were discontinued prior to randomization. This reporting group includes all randomized participants (64).

Participants by arm

ArmCount
Overall
Habitual contact lenses worn first, followed by stenfilcon A contact lenses and narafilcon A contact lenses in Periods 1 and 2 as randomized. Each product worn bilaterally for 10 days in a daily wear, daily disposable modality.
64
Total64

Withdrawals & dropouts

PeriodReasonFG000FG001
Habitual, 10 Days of WearWithdrawal by Subject11
Period 1, 10 Days of WearWithdrawal by Subject11

Baseline characteristics

CharacteristicOverall
Age, Continuous33.8 years
STANDARD_DEVIATION 9.71
Sex: Female, Male
Female
45 Participants
Sex: Female, Male
Male
19 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —— / —
other
Total, other adverse events
0 / 665 / 320 / 320 / 600 / 61
serious
Total, serious adverse events
0 / 660 / 320 / 321 / 601 / 61

Outcome results

Primary

High Contrast Time-Controlled Visual Acuity (TCVA) (VA Unit) Post-Exposure to Reduced Humidity at Day 10

High contrast TCVA was assessed after 3 hours exposure to reduced humidity environment. TCVA test was performed at 4 meters under high illumination (90%) using a Landolt ring test. For each acuity level, a series of single rings with gaps in one of four directions was presented and the percentage of correctly identified rings constituted the score. TCVA was measured in VA units and a higher TCVA value indicates an improvement in visual acuity. Both eyes contributed to the analysis.

Time frame: Day 10, each product

Population: Intent to Treat

ArmMeasureValue (MEAN)Dispersion
MyDayHigh Contrast Time-Controlled Visual Acuity (TCVA) (VA Unit) Post-Exposure to Reduced Humidity at Day 100.453 VA unitStandard Deviation 0.673
1DAVTEHigh Contrast Time-Controlled Visual Acuity (TCVA) (VA Unit) Post-Exposure to Reduced Humidity at Day 100.341 VA unitStandard Deviation 0.781
Secondary

High Contrast TCVA (VA Unit) Pre-Exposure to Reduced Humidity at Day 10

High contrast TCVA was assessed after 3 hours exposure to normal environment and prior to exposure to reduced humidity environment. Both eyes contributed to the analysis.

Time frame: Day 10, each product

Population: Intent to Treat Subjects

ArmMeasureValue (MEAN)Dispersion
MyDayHigh Contrast TCVA (VA Unit) Pre-Exposure to Reduced Humidity at Day 100.614 VA unitStandard Deviation 0.689
1DAVTEHigh Contrast TCVA (VA Unit) Pre-Exposure to Reduced Humidity at Day 100.700 VA unitStandard Deviation 0.777

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026